BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38387812)

  • 1. A Novel Framework for Thermoradiotherapy Treatment Planning.
    Ödén J; Eriksson K; Pavoni B; Crezee H; Kok HP
    Int J Radiat Oncol Biol Phys; 2024 Feb; ():. PubMed ID: 38387812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.
    Corletto D; Iori M; Paiusco M; Brait L; Broggi S; Ceresoli G; Iotti C; Calandrino R; Fiorino C
    Radiother Oncol; 2003 Feb; 66(2):185-95. PubMed ID: 12648791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voxel-Level BED Corrected Dosimetric and Radiobiological Assessment of 2 Kinds of Hybrid Radiotherapy Planning Methods for Stage III NSCLC.
    Wang H; Huang Y; Chen H; Shao Y; Duan Y; Feng A; Gu H; Ma X; Xu Z; Kong Q; Zhou Y
    Technol Cancer Res Treat; 2022; 21():15330338221107966. PubMed ID: 35731648
    [No Abstract]   [Full Text] [Related]  

  • 4. Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions.
    Zeng C; Giantsoudi D; Grassberger C; Goldberg S; Niemierko A; Paganetti H; Efstathiou JA; Trofimov A
    Med Phys; 2013 May; 40(5):051708. PubMed ID: 23635256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer.
    Royce TJ; Mavroidis P; Wang K; Falchook AD; Sheets NC; Fuller DB; Collins SP; El Naqa I; Song DY; Ding GX; Nahum AE; Jackson A; Grimm J; Yorke E; Chen RC
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):227-236. PubMed ID: 32900561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technical note: Optimization functions for re-irradiation treatment planning.
    Ödén J; Eriksson K; Svensson S; Lilley J; Thompson C; Pagett C; Appelt A; Murray L; Bokrantz R
    Med Phys; 2024 Jan; 51(1):476-484. PubMed ID: 37921262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D radiobiological evaluation of combined radiotherapy and hyperthermia treatments.
    van Leeuwen CM; Crezee J; Oei AL; Franken NAP; Stalpers LJA; Bel A; Kok HP
    Int J Hyperthermia; 2017 Mar; 33(2):160-169. PubMed ID: 27744728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer.
    Sukhikh ES; Sukhikh LG; Taletsky AV; Vertinsky AV; Izhevsky PV; Sheino IN
    Phys Med; 2019 Jun; 62():41-46. PubMed ID: 31153397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantifying the combined effect of radiation therapy and hyperthermia in terms of equivalent dose distributions.
    Kok HP; Crezee J; Franken NA; Stalpers LJ; Barendsen GW; Bel A
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):739-45. PubMed ID: 24411189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Image-guided adaptive radiation therapy (IGART): Radiobiological and dose escalation considerations for localized carcinoma of the prostate.
    Song W; Schaly B; Bauman G; Battista J; Van Dyk J
    Med Phys; 2005 Jul; 32(7Part1):2193-2203. PubMed ID: 28493587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiobiological impact of planning techniques for prostate cancer in terms of tumor control probability and normal tissue complication probability.
    Rana S; Cheng C
    Ann Med Health Sci Res; 2014 Mar; 4(2):167-72. PubMed ID: 24761232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SU-E-T-02: Radiobiological Comparison of Two Treatment Schemas in IMRT Prostate Radiotherapy.
    Hernández TG; González AV; Cabañero DG; González LB; Ferrando JR; Peidro JP; Torrecilla JL
    Med Phys; 2012 Jun; 39(6Part9):3702. PubMed ID: 28519019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of the effects of internal organ motion on dose escalation in conformal prostate treatments.
    Happersett L; Mageras GS; Zelefsky MJ; Burman CM; Leibel SA; Chui C; Fuks Z; Bull S; Ling CC; Kutcher GJ
    Radiother Oncol; 2003 Mar; 66(3):263-70. PubMed ID: 12742265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
    Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiobiological impact of reduced margins and treatment technique for prostate cancer in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP).
    Jensen I; Carl J; Lund B; Larsen EH; Nielsen J
    Med Dosim; 2011; 36(2):130-7. PubMed ID: 20488692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement and analysis of the impact of time-interval, temperature and radiation dose on tumour cell survival and its application in thermoradiotherapy plan evaluation.
    van Leeuwen CM; Oei AL; Ten Cate R; Franken NAP; Bel A; Stalpers LJA; Crezee J; Kok HP
    Int J Hyperthermia; 2018 Feb; 34(1):30-38. PubMed ID: 28540813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity modulated radiation therapy dose painting for localized prostate cancer using ¹¹C-choline positron emission tomography scans.
    Chang JH; Lim Joon D; Lee ST; Gong SJ; Anderson NJ; Scott AM; Davis ID; Clouston D; Bolton D; Hamilton CS; Khoo V
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e691-6. PubMed ID: 22658218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of setup and range uncertainties on TCP and NTCP following VMAT or IMPT of oropharyngeal cancer patients.
    Hamming-Vrieze O; Depauw N; Craft DL; Chan AW; Rasch CRN; Verheij M; Sonke JJ; Kooy HM
    Phys Med Biol; 2019 Apr; 64(9):095001. PubMed ID: 30921775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.